The Canadian Rheumatology Association (CRA) is aware of the increasing number of questions rheumatologists are receiving pertaining to hydroxychloroquine (HCQ) and cardiotoxicity. Today, we have released a position statement which provides clarification on the safety of HCQ in the treatment of rheumatic diseases.
See their position statement below: